Answers are grounded in this paper and cite their sources.
Structural analysis of minor components in mixtures is a vital requirement in the development of any pharmaceutical compound. Mass spectrometry is uniquely able to give this kind of information on the trace amounts of material present as minor impurities in a drug substance. In this study we show that a combination of mass spectrometric analysers with different characteristics is an even more powerful approach with a higher chance of establishing a potential structure. In particular the advent of analysers capable of accurate mass measurement on small amounts of material has enabled structures to be proposed in situations where previously no real conclusions could be made.
No takes yet. Share an insight, caveat, or question.
Wolff et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: